Psyched Wellness Is Pleased To Announce Partnership with National Sales and Distribution Organization, POD Foods
Toronto, Ontario--(Newsfile Corp. - August 3, 2023) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
Month: August 2023
Tryp Therapeutics Announces Jason Carroll as New Chief Executive Officer
KELOWNA, BC / ACCESSWIRE / August 3, 2023 / Tryp Therapeutics Inc. (CSE:TRYP)(OTCQB:TRYPF) ("Tryp" or the "Company"), a clinical-stage biotechnology...
Encision Reports First Quarter Fiscal Year 2024 Results
BOULDER, CO / ACCESSWIRE / August 3, 2023 / Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode...
Milestone in Psychedelic Wellness: Silo Wellness and NUGL’s (Kaya Jamaica) Share Exchange Paves Way for Expansion and Collaboration
Springfield, Oregon--(Newsfile Corp. - August 3, 2023) - Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A) ("Silo" or "the...
KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on...
MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders
NEW YORK--(BUSINESS WIRE)--MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company”) today announced that it convened and then adjourned, without...
Glaukos Announces Second Quarter 2023 Financial Results
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...
Outset Medical Reports Second Quarter 2023 Financial Results
Sequential Revenue Growth of 8%, Ninth Consecutive Quarter of Gross Margin Expansion Announces Shipment Pause of TabloCart with Prefiltration Pending...
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 2, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release...
Glow LifeTech Launches Two Cannabis Consumer Brands, MOD and .decimal, Featuring Its Rapid Onset Liquid and Powder Ingredient Technologies
Toronto, Ontario--(Newsfile Corp. - August 2, 2023) - Glow LifeTech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or...
Imperative Care Announces NVQI Registry Data on the Real-World Performance of the Zoom Aspiration Catheters for Ischemic Stroke Treatment
Late-Breaking Data Presented at the Society of NeuroInterventional Surgery Annual Meeting Demonstrate High Rates of Successful Reperfusion and Rapid Procedure...
Cosmos Health Continues to Expand Mediterranation Brand, Welcomes Eleonas and Olympus Mons; Boosts Exports and Secures Purchase Orders, Including from Leading Multinational Health Food Chain
CHICAGO, IL / ACCESSWIRE / August 2, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a global...
Bayer Collaborates in Value-Chain Partnerships
NORTHAMPTON, MA / ACCESSWIRE / August 2, 2023 / BayerAs no one can overcome every challenge alone, we establish crop...
Springfield Clinic to Move to athenahealth’s Cloud-Based EHR
Illinois’ second-largest private, multispecialty medical group will leverage athenaOne® to simplify the practice of care and improve patient experience and...
Glytec Simplifies Glycemic Management for Clinicians and Pharmacists with New Glucommander® Enhancements
Innovations Leverage Practitioner Feedback and Field Testing to Streamline Workflows, Speed Time to Value and Deliver Enhanced EHR Support while...
Glytec Simplifies Glycemic Management for Clinicians and Pharmacists with New Glucommander® Enhancements
Innovations Leverage Practitioner Feedback and Field Testing to Streamline Workflows, Speed Time to Value and Deliver Enhanced EHR Support while...
Cardio Diagnostics Holdings, Inc Announces Expansion of IP Portfolio in Australia with Notice of Allowance of Patent Application
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced that Australia’s...
Cardio Diagnostics Holdings, Inc Announces Expansion of IP Portfolio in Australia with Notice of Allowance of Patent Application
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced that Australia’s...
LENSAR to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser...
LENSAR to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser...